How MERS-CoV Regulates Innate Immunity in Primary Human Lung Cells

NIH RePORTER · NIH · R21 · $27,486 · view on reporter.nih.gov ↗

Abstract

ABSTRACT The molecular mechanisms regulating emerging highly pathogenic human respiratory coronavirus pathogenesis are complex and include dampening of the host innate immune response allowing higher viral titers immediately following entry. Previous studies tracking the expression of interferon stimulated gene (ISG) expression in Middle East respiratory syndrome coronavirus (MERS-CoV) infected continuous human lung epithelial cells demonstrated that specific ISG expression patterns could be detected and these patterns could be used to determine how CoV were modulating the innate immune response. Epigenetic/chromatin remodeling mechanisms were found to be important regulators of host chromatin remodeling that altered host expression ISG patterns. This proposal will build on these foundational studies performed in continuous human lung cell lines and define ways that MERS-CoV regulates innate immunity in primary human lung fibroblasts and microvascular endothelial cells.

Key facts

NIH application ID
9942367
Project number
5R21AI146872-02
Recipient
UNIV OF NORTH CAROLINA CHAPEL HILL
Principal Investigator
AMY C SIMS
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$27,486
Award type
5
Project period
2019-06-05 → 2020-06-02